Blue Trust’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-400
Closed -$5.9K – 2743
2026
Q2
$5.9K Buy
+400
New +$2.76K ﹤0.01% 1999

Other funds holding SLS

Blue Trust's SLS Position: Q3 2026 in Review

Blue Trust sold out of SELLAS Life Sciences (SLS) in Q3 2026, closing a stake of 400 shares — an estimated $5.9K sold.

Blue Trust first reported a position in SLS in Q2 2026 and held it in 1 quarter. The position peaked at $5.9K in Q2 2026. 168 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Blue Trust reported no remaining SELLAS Life Sciences position as of Q3 2026 after selling out during the quarter.
  • Blue Trust sold 400 SELLAS Life Sciences shares in Q3 2026, an estimated $5.9K.
  • Blue Trust first reported a position in SELLAS Life Sciences in Q2 2026 and held it in 1 quarter.
  • Blue Trust's SELLAS Life Sciences position peaked at $5.9K in Q2 2026.
  • 168 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.